Inventor · disambiguated record
Suneel Gupta
Also filed as: GUPTA SUNEEL · GUPTA SUNEEL K · GUPTA SUNEEL KUMAR
47 granted patents·24 pending applications·1,125 citations·filing 1995–2025
98Inventor score
Files withALZA CORP14AMNEAL PHARMACEUTICALS LLC14IMPAX LABORATORIES LLC14IMPAX LABORATORIES INC4PROTAGONIST THERAPEUTICS INC4
Top patents by PatentIndex Score
71 records- 0198US11666538B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2022·Granted Jun 6, 2023·16 cites·21 claims
- 0298US11622941B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Apr 11, 2023·16 cites·29 claims
- 0398US11357733B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2021·Granted Jun 14, 2022·20 cites·40 claims
- 0498US10987313B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Apr 27, 2021·29 cites·44 claims
- 0598US10973769B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2020·Granted Apr 13, 2021·28 cites·27 claims
- 0697US10688058B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2019·Granted Jun 23, 2020·32 cites·22 claims
- 0797US10292935B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2016·Granted May 21, 2019·30 cites·20 claims
- 0897US6930129B2Methods and devices for providing prolonged drug therapyALZA CORP·Filed 2001·Granted Aug 16, 2005·126 cites·10 claims
- 0997US6919373B1Methods and devices for providing prolonged drug therapyALZA CORP·Filed 1999·Granted Jul 19, 2005·317 cites·8 claims
- 1096US12178919B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·1 cites·23 claims
- 1195US12064521B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2023·Granted Aug 20, 2024·1 cites·20 claims
- 1295US10098845B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES INC·Filed 2014·Granted Oct 16, 2018·28 cites·22 claims
- 1395US8163798B2Methods and devices for providing prolonged drug therapyGUPTA SUNEEL K·Filed 2003·Granted Apr 24, 2012·68 cites·11 claims
- 1494US11986449B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2022·Granted May 21, 2024·1 cites·17 claims
- 1593US12403099B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Sep 2, 2025·0 cites·19 claims
- 1693US12303605B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted May 20, 2025·0 cites·26 claims
- 1793US12274793B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Apr 15, 2025·0 cites·22 claims
- 1892US12295931B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted May 13, 2025·0 cites·25 claims
- 1992US12201596B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted Jan 21, 2025·0 cites·17 claims
- 2092US12178918B2Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Dec 31, 2024·0 cites·21 claims
- 2192US12128141B1Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2024·Granted Oct 29, 2024·0 cites·18 claims
- 2292US7011844B2Formulations for the administration of fluoxetineALZA CORP·Filed 2002·Granted Mar 14, 2006·29 cites·10 claims
- 2391US12491164B2Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereofIMPAX LABORATORIES LLC·Filed 2025·Granted Dec 9, 2025·0 cites·19 claims
- 2491US12303481B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted May 20, 2025·0 cites·21 claims
- 2591US12263149B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted Apr 1, 2025·0 cites·21 claims
- 2691US12263148B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted Apr 1, 2025·0 cites·28 claims
- 2791US12194150B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2021·Granted Jan 14, 2025·2 cites·14 claims
- 2891US12109185B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2024·Granted Oct 8, 2024·0 cites·32 claims
- 2991US9144549B2Methods and devices for providing prolonged drug therapyALZA CORP·Filed 2013·Granted Sep 29, 2015·5 cites·32 claims
- 3090US9393192B2Methods and dosage forms for controlled delivery of paliperidone and risperidoneYAM NYOMI V·Filed 2009·Granted Jul 19, 2016·55 cites·14 claims
- 3190US9000038B2Methods and devices for providing prolonged drug therapyALZA CORP·Filed 2013·Granted Apr 7, 2015·5 cites·12 claims
- 3290US8629179B2Methods and devices for providing prolonged drug therapyGUPTA SUNEEL K·Filed 2009·Granted Jan 14, 2014·6 cites·18 claims
- 3390US6512010B1Formulations for the administration of fluoxetineALZA CORP·Filed 1997·Granted Jan 28, 2003·76 cites·34 claims
- 3490US2024315999A1Levodopa dosage formAMNEAL PHARMACEUTICALS LLC·Filed 2024·Application pending·0 cites
- 3580US5983130AElectrotransport agent delivery method and apparatusALZA CORP·Filed 1995·Granted Nov 9, 1999·159 cites·20 claims
- 3678US12458616B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2025·Granted Nov 4, 2025·0 cites·26 claims
- 3778US12453710B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2025·Granted Oct 28, 2025·0 cites·24 claims
- 3878US12447139B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2025·Granted Oct 21, 2025·0 cites·24 claims
- 3978US12370163B2Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2025·Granted Jul 29, 2025·0 cites·32 claims
- 4078US12303482B1Levodopa dosing regimenAMNEAL PHARMACEUTICALS LLC·Filed 2025·Granted May 20, 2025·0 cites·29 claims
- 4174US9029416B2Methods and devices for providing prolonged drug therapyLAM ANDREW C·Filed 2003·Granted May 12, 2015·5 cites·46 claims
- 4271US2008021102A1Method for the Management of IncontinenceALZA CORP·Filed 2007·Application pending·0 cites
- 4365US2016296463A1Rapidly disintegrating formulations and methods thereofIMPAX LABORATORIES INC·Filed 2014·Application pending·0 cites
- 4464US2023382998A1METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES WITH a4B7 INTEGRIN ANTAGONISTSPROTAGONIST THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4564US2019365641A1Rapidly disintegrating formulations and methods of useIMPAX LABORATORIES INC·Filed 2019·Application pending·0 cites
- 4662US2005186277A1Novel formulations for the administration of fluoxetineFiled 2005·Application pending·0 cites
- 4759US2022372099A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4858US2021061872A1Conjugated hepcidin mimeticsPROTAGONIST THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4957US2024293511A1Hepcidin mimetics for treatment of hereditary hemochromatosisPROTAGONIST THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5056US2012283275A1Methods and dosage forms for reducing side effects of benzisozazole derivativesSATHYAN GAYATRI·Filed 2012·Application pending·0 cites
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Suneel Gupta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →